MRC1 and cancer: Addition of recombinant oncostatin M and Eotaxin to normoxic cancer cell CM resulted in enhanced directional migration of macrophages with a concurrent increase in their polarization towards an M2-skewed phenotype as measured through flowcytometric detection of CD206.